Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

103420-78-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)-

    Cas No: 103420-78-6

  • Need to discuss

  • No requirement

  • Adequate

  • Chemwill Asia Co., Ltd.
  • Contact Supplier
  • 103420-78-6 Structure
  • Basic information

    1. Product Name: 1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)-
    2. Synonyms:
    3. CAS NO:103420-78-6
    4. Molecular Formula: C25H19FN4O2
    5. Molecular Weight: 426.45
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 103420-78-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)-(103420-78-6)
    11. EPA Substance Registry System: 1H-Indole-2-carboxamide, N-[5-(2-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin -3-yl]-, (S)-(103420-78-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 103420-78-6(Hazardous Substances Data)

103420-78-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 103420-78-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,4,2 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 103420-78:
(8*1)+(7*0)+(6*3)+(5*4)+(4*2)+(3*0)+(2*7)+(1*8)=76
76 % 10 = 6
So 103420-78-6 is a valid CAS Registry Number.

103420-78-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Indole-2-carboxylic acid [(S)-5-(2-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-amide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103420-78-6 SDS

103420-78-6Downstream Products

103420-78-6Relevant articles and documents

Methods for Drug Discovery: Development of Potent, Selective, Orally Effecive Cholecystokinin Antagonists

Evans, B. E.,Rittle, K. E.,Bock, M. G.,DiPardo, R. M.,Freidinger, R. M.,et al.

, p. 2235 - 2246 (2007/10/02)

3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines, antagonists of the peptide hormone cholecystokinin (CCK), are described.Developed by reasoned modification of the known anxiolytic benzodiazepines, these compounds provide highly potent, orally effective ligands selective for peripheral (CCK-A) receptors, with binding affinities approaching or equaling that of the natural ligand CCK-8.The distinction between CCK-A receptors on the one hand and CNS (CCK-B), gastrin, and central benzodiazepine receptors on the other is demonstrated by using the structure-activity profiles of the new compounds.Details of the binding of these agents to CCK-A receptors are examined, and the method of development of these compounds is discussed in terms of its relevance to the general problem of drug discovery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103420-78-6